BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32703135)

  • 1. Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer.
    Shukla N; Siva N; Malik B; Suravajhala P
    Curr Top Med Chem; 2020; 20(22):1968-1980. PubMed ID: 32703135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next Generation Sequencing Data and Proteogenomics.
    Ruggles KV; Fenyö D
    Adv Exp Med Biol; 2016; 926():11-19. PubMed ID: 27686803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.
    Barbieri R; Guryev V; Brandsma CA; Suits F; Bischoff R; Horvatovich P
    Adv Exp Med Biol; 2016; 926():21-47. PubMed ID: 27686804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
    Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
    Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteogenomic Tools and Approaches to Explore Protein Coding Landscapes of Eukaryotic Genomes.
    Kumar D; Dash D
    Adv Exp Med Biol; 2016; 926():1-10. PubMed ID: 27686802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of clinical proteogenomics in lung cancer.
    Nishimura T; Nakamura H; Végvári Á; Marko-Varga G; Furuya N; Saji H
    Expert Rev Proteomics; 2019 Sep; 16(9):761-772. PubMed ID: 31402712
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
    Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
    Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
    Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting Proteomics to Next-Generation Sequencing: Proteogenomics and Its Current Applications in Biology.
    Low TY; Mohtar MA; Ang MY; Jamal R
    Proteomics; 2019 May; 19(10):e1800235. PubMed ID: 30431238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteogenomics data-driven knowledge base of human cancer.
    Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
    Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for Optimization of Protein Extraction and Proteogenomic Mapping in Sweet Potato.
    Al-Mohanna T; Bokros NT; Ahsan N; Popescu GV; Popescu SC
    Methods Mol Biol; 2020; 2139():309-324. PubMed ID: 32462596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate Prediction of Protein Sequences for Proteogenomics Data Integration.
    Hagemeijer YP; Guryev V; Horvatovich P
    Methods Mol Biol; 2022; 2420():233-260. PubMed ID: 34905178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteogenomics of Malignant Melanoma Cell Lines: The Effect of Stringency of Exome Data Filtering on Variant Peptide Identification in Shotgun Proteomics.
    Lobas AA; Pyatnitskiy MA; Chernobrovkin AL; Ilina IY; Karpov DS; Solovyeva EM; Kuznetsova KG; Ivanov MV; Lyssuk EY; Kliuchnikova AA; Voronko OE; Larin SS; Zubarev RA; Gorshkov MV; Moshkovskii SA
    J Proteome Res; 2018 May; 17(5):1801-1811. PubMed ID: 29619825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteogenomics in the context of the Human Proteome Project (HPP).
    González-Gomariz J; Guruceaga E; López-Sánchez M; Segura V
    Expert Rev Proteomics; 2019 Mar; 16(3):267-275. PubMed ID: 30654666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteogenomics: concepts, applications and computational strategies.
    Nesvizhskii AI
    Nat Methods; 2014 Nov; 11(11):1114-25. PubMed ID: 25357241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False discovery rate: the Achilles' heel of proteogenomics.
    Aggarwal S; Raj A; Kumar D; Dash D; Yadav AK
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35534181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-model organisms, a species endangered by proteogenomics.
    Armengaud J; Trapp J; Pible O; Geffard O; Chaumot A; Hartmann EM
    J Proteomics; 2014 Jun; 105():5-18. PubMed ID: 24440519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Proteogenomic Landscape of Curable Prostate Cancer.
    Sinha A; Huang V; Livingstone J; Wang J; Fox NS; Kurganovs N; Ignatchenko V; Fritsch K; Donmez N; Heisler LE; Shiah YJ; Yao CQ; Alfaro JA; Volik S; Lapuk A; Fraser M; Kron K; Murison A; Lupien M; Sahinalp C; Collins CC; Tetu B; Masoomian M; Berman DM; van der Kwast T; Bristow RG; Kislinger T; Boutros PC
    Cancer Cell; 2019 Mar; 35(3):414-427.e6. PubMed ID: 30889379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the Chromosome-centric and Biology/Disease-driven Human Proteome Projects: Accessible and Automated Tools for Interpreting the Biological and Pathological Impact of Protein Sequence Variants Detected via Proteogenomics.
    Sajulga R; Mehta S; Kumar P; Johnson JE; Guerrero CR; Ryan MC; Karchin R; Jagtap PD; Griffin TJ
    J Proteome Res; 2018 Dec; 17(12):4329-4336. PubMed ID: 30130115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
    Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
    Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.